Substituted aminobutyric derivatives as neprilysin inhibitors
US9603819B2 · kind B2 · utility
0Cited by
23References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 2, 2015 |
| Grant date | Mar 28, 2017 |
| Priority date | — |
| Expiry date | May 23, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a compound of formula I′;or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, X and n are defined herein. The invention also relates to a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.